Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Histone H2A monoubiquitylation and p38-MAPKs regulate immediate-early gene-like reactivation of latent retrovirus HTLV-1
Anurag Kulkarni, Graham P. Taylor, Robert J. Klose, Christopher J. Schofield, Charles R.M. Bangham
Anurag Kulkarni, Graham P. Taylor, Robert J. Klose, Christopher J. Schofield, Charles R.M. Bangham
View: Text | PDF
Research Article Virology

Histone H2A monoubiquitylation and p38-MAPKs regulate immediate-early gene-like reactivation of latent retrovirus HTLV-1

  • Text
  • PDF
Abstract

It is not understood how the human T cell leukemia virus human T-lymphotropic virus-1 (HTLV-1), a retrovirus, regulates the in vivo balance between transcriptional latency and reactivation. The HTLV-1 proviral plus-strand is typically transcriptionally silent in freshly isolated peripheral blood mononuclear cells from infected individuals, but after short-term ex vivo culture, there is a strong, spontaneous burst of proviral plus-strand transcription. Here, we demonstrate that proviral reactivation in freshly isolated, naturally infected primary CD4+ T cells has 3 key attributes characteristic of an immediate-early gene. Plus-strand transcription is p38-MAPK dependent and is not inhibited by protein synthesis inhibitors. Ubiquitylation of histone H2A (H2AK119ub1), a signature of polycomb repressive complex-1 (PRC1), is enriched at the latent HTLV-1 provirus, and immediate-early proviral reactivation is associated with rapid deubiquitylation of H2A at the provirus. Inhibition of deubiquitylation by the deubiquitinase (DUB) inhibitor PR619 reverses H2AK119ub1 depletion and strongly inhibits plus-strand transcription. We conclude that the HTLV-1 proviral plus-strand is regulated with characteristics of a cellular immediate-early gene, with a PRC1-dependent bivalent promoter sensitive to p38-MAPK signaling. Finally, we compare the epigenetic signatures of p38-MAPK inhibition, DUB inhibition, and glucose deprivation at the HTLV-1 provirus, and we show that these pathways act as independent checkpoints regulating proviral reactivation from latency.

Authors

Anurag Kulkarni, Graham P. Taylor, Robert J. Klose, Christopher J. Schofield, Charles R.M. Bangham

×

Figure 2

PRC1 signature at the HTLV-1 provirus.

Options: View larger image (or click on image) Download as PowerPoint
PRC1 signature at the HTLV-1 provirus.
Cryopreserved HTLV-1–infected PBM...
Cryopreserved HTLV-1–infected PBMCs were subjected to ChIP and the precipitate amplified by qPCR with primers specific respectively for the 5′-LTR and 3′-LTR junctions of the HTLV-1 provirus. (A) ChIP-qPCR using antibody against EZH2 (PRC2 enzyme) after 0 hr (T0) and 17 hr (17h) of culture. (B) ChIP-qPCR with antibody against H2AK119ub1 (PRC1 epigenetic mark) after 0 hr, 2 hr, and 17 hr of culture. Enrichment is expressed as percent input DNA in the ChIP. Statistical significance was calculated using the 2-tailed Student’s t test (*P < 0.05; **P < 0.005). n = 4 for both A and B.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts